Caredx to present at the h.c. wainwright 25th annual global investment conference

Brisbane, calif.--(business wire)--caredx, inc. (nasdaq: cdna), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the company will participate in the h.c. wainwright 25th annual global investment conference. caredx's management is scheduled to present at the h.c. wainwright 25th annual global investment conference on tuesday,.
CDNA Ratings Summary
CDNA Quant Ranking